ALX Oncology Holdings Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and thank you, everyone, for joining us today. I'm Kat Lange, a member of the JPMorgan Health Care Investment Banking team. As a quick reminder, after the presentation ends, we will do a quick Q&A session. So if you would like to submit a question, please hit the blue button titled ask a question.
And with that, I would like to hand it over to Jaume Pons, President and CEO of ALX Oncology.
Yes. Thank you, Kat. Good morning. I really appreciate the opportunity to share our data with you today.
After the customary disclaimers in Page #2, let's move to Slide #3. When I started the company in 2015, I was very fortunate to be able to bring with me my dream team of professionals. Today, I want to introduce very specially, Dr. Sophia Randolph, our Chief Medical Officer, and she was a global clinical franchise lead for IBRANCE, the CDK inhibitor of Pfizer, that she developed
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |